-transparent.png){kind=logo}
According to our hypothesis, bacterial lectins play an important role in the organotropy of infectious diseases which is analogous to the metastasis of tumor cells. As a model for proving this, we investigated the specific lectin of Streptococcus pneumoniae, which has N-acetyl-D-glucosamine/D-galactose (GlcNAc-Gal) specificity. In vitro, after incubation with Streptococcus pneumoniae, cryotome sections of various organs from Balb/c-mice showed remarkable quantitative differences of bacterial adhesion to the organ cells. Whereas lungs and meninges were closely settled with bacteria, attachment to other organs (e.g. liver, spleen, brain) was lacking. In vitro lectin-blocking by GlcNAc completely prevented the adherence of Streptococcus pneumoniae to lungs and meninges. Other non-related carbohydrates (e.g. D-mannose, D-xylose) showed no effect. During in vivo experiments with Balb/c-mice, intratracheal application of Streptococcus pneumoniae led to a diffuse settlement of the lung. However, bacterial lectin-blocking with intratracheal GlcNAc administration completely inhibited adhesion to the organ cells of the lung. Therefore blocking of bacterial adhesins with competitive specific monosaccharides can completely prevent bacterial adhesion processes, a fact, which opens therapeutical aspects.
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
January 1999,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
January 1995,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
February 1999,
Microbial pathogenesis,
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
July 2006,
Journal of bacteriology,
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
January 2019,
Methods in molecular biology (Clifton, N.J.),
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
January 1997,
Drugs,
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
June 1997,
The Journal of antimicrobial chemotherapy,
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
January 2020,
Frontiers in molecular biosciences,
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
March 2006,
Vaccine,
J Beuth, and
H L Ko, and
H Schroten, and
J Sölter, and
G Uhlenbruck, and
G Pulverer
November 2003,
The Journal of biological chemistry,
